Register Login

Insmed Inc (INSM)

Director Lewis William 🟡 adjusted position in 19.2K shares (2 derivative) of INSMED Inc (INSM) at $174.86 ($3.8M) Transaction Date: Jan 12, 2026 | Filing ID: 000007

Full text
Register to leave comments
  • News bot Jan. 13, 2026, 9:07 p.m.

    🔍 Lewis William (Director)

    Company: INSMED Inc (INSM)

    Report Date: 2026-01-12

    Transaction Summary:

    • Total transactions: 13
    • Derivative instruments: 2
    • Holdings reported: 2
    • Total shares acquired: 10,699
    • Total shares sold: 29,914
    • Total shares held: 284,424

    Detailed Transactions and Holdings:

    • Acquired 6,259 shares of Common Stock at $30.46 per share (Direct)
      Date: 2026-01-12 | Code: M | equity_swap_involved: 0 | shares_owned_after: 321,666.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 4,440 shares of Common Stock at $17.16 per share (Direct)
      Date: 2026-01-12 | Code: M | equity_swap_involved: 0 | shares_owned_after: 326,106.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 3,974 shares of Common Stock at $167.73 per share (Direct)
      Date: 2026-01-12 | Code: S | equity_swap_involved: 0 | shares_owned_after: 322,132.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 7,176 shares of Common Stock at $168.63 per share (Direct)
      Date: 2026-01-12 | Code: S | equity_swap_involved: 0 | shares_owned_after: 314,956.00 | transaction_form_type: 4 | Footnotes: F1, F3
    • Sold 6,996 shares of Common Stock at $169.57 per share (Direct)
      Date: 2026-01-12 | Code: S | equity_swap_involved: 0 | shares_owned_after: 307,960.00 | transaction_form_type: 4 | Footnotes: F1, F4
    • Sold 160 shares of Common Stock at $170.24 per share (Direct)
      Date: 2026-01-12 | Code: S | equity_swap_involved: 0 | shares_owned_after: 307,800.00 | transaction_form_type: 4 | Footnotes: F1, F5
    • Sold 297 shares of Common Stock at $171.31 per share (Direct)
      Date: 2026-01-12 | Code: S | equity_swap_involved: 0 | shares_owned_after: 307,503.00 | transaction_form_type: 4 | Footnotes: F1, F6
    • Sold 297 shares of Common Stock at $172.36 per share (Direct)
      Date: 2026-01-12 | Code: S | equity_swap_involved: 0 | shares_owned_after: 307,206.00 | transaction_form_type: 4 | Footnotes: F1, F7
    • Sold 315 shares of Common Stock at $174.86 per share (Direct)
      Date: 2026-01-12 | Code: S | equity_swap_involved: 0 | shares_owned_after: 306,891.00 | transaction_form_type: 4 | Footnotes: F1
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-01-12 | Code: H | nature_of_ownership: By the Katie Procter Dynasty Trust | shares_owned_after: 233,924.00
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-01-12 | Code: H | nature_of_ownership: By the William Lewis Family Legacy Trust | shares_owned_after: 50,500.00
    • Sold 6,259 shares of Stock Option (right to buy) at $30.46 per share (Derivative)
      Date: 2026-01-12 | Code: M | Expires: 2028-01-04 | equity_swap_involved: 0 | shares_owned_after: 81,368.00 | transaction_form_type: 4 | Footnotes: F1, F8
    • Sold 4,440 shares of Stock Option (right to buy) at $17.16 per share (Derivative)
      Date: 2026-01-12 | Code: M | Expires: 2027-05-17 | equity_swap_involved: 0 | shares_owned_after: 57,720.00 | transaction_form_type: 4 | Footnotes: F1, F8

    Footnotes:

    • F1: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 4, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
    • F2: This is the weighted average sales price representing 3,974 shares sold at prices ranging from $167.11 to $168.02 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
    • F3: This is the weighted average sales price representing 7,176 shares sold at prices ranging from $168.11 to $169.10 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
    • F4: This is the weighted average sales price representing 6,996 shares sold at prices ranging from $169.11 to $170.08 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
    • F5: This is the weighted average sales price representing 160 shares sold at prices ranging from $170.12 to $170.89 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
    • F6: This is the weighted average sales price representing 297 shares sold at prices ranging from $171.21 to $171.52 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
    • F7: This is the weighted average sales price representing 297 shares sold at prices ranging from $172.26 to $172.42 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
    • F8: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.

Search

News categories